Patient Basic Information Patient: Mr. Charles (Charles Sanchez) Nationality: Cyprus Diagnosis: Thyroid cancer Diagnostic Hospital: First People's Hospital in Shanghai Treatment: Organ transplant + anti-rejection treatment Holidays: 79 days Treatment cost: about 1205574 yuan Treatment effect: complete mitigation The patient is from Cyprus, where he is not diagnosed with thyroid cancer. Upon arrival at the First People's Hospital in Shanghai, the International Medical Services team arranged for the first time multidisciplinary MDT for patients, developed individualized pathways based on the patient's examination reports and physical condition, and provided translation, accompaniment and landing services throughout the treatment process.
The team of experts at the First People's Hospital in Shanghai used a comprehensive system of organ transplantation + anti-rejection treatment, during which the medical team closely monitored the patient's indicators, dynamic adjustment programs. After 79 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching hospital standards. The patient's treatment effects were finally completely alleviated.
When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to monitor the recovery through a remote follow-up system. The patient commented: 'The level of expertise of Chinese doctors and the condition of the equipment in Chinese hospitals impressed us that every link from the ground to the hospital was arranged with a well. Thank you to the medical team at the First People's Hospital in Shanghai, and thank you for the attentive care of the translators and attendants.
'Mr. Liu Charles, experts have criticized this case as a typical case of cross-border suspected serious medical conditions. The Shanghai First People's Hospital relies on a multidisciplinary collaborative mechanism to develop organ transplant + anti-rejection treatments for thyroid cancer, which reflects the comprehensive strength of Chinese hospitals in the field of suspected disease diagnosis and is a shorthand for the regulation of international visitor medical services.